Advinus Therapeutics and P2D Bioscience Enter Into a Research and Development Collaboration for Attention Deficit Hyperactivity Disorder (ADHD)

Advinus Therapeutics Ltd., a drug discovery and development company, and P2D Bioscience, a CNS-focused specialty pharmaceutical company, have initiated a research and development collaboration to develop therapies for Attention Deficit Hyperactivity Disorder (ADHD).

Visit P2Dinc.com to learn more.